1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol

Catalog No. :
ACTKQI986
CAS No. :
24342-68-5
Molecular Formula :
C19H32O7
Molecular Weight :
372.46

IUPAC Name:1-phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol

1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$56.00Login to see priceIn stockInquiry
25g98%$274.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol
IUPAC Name1-phenyl-2,5,8,11,14,17-hexaoxanonadecan-19-ol
MDL No.MFCD06797107
Molecular FormulaC19H32O7
Molecular Weight372.46
SMILESOCCOCCOCCOCCOCCOCCOCC1=CC=CC=C1
InChI KeyVVBQKDDPSXBMMZ-UHFFFAOYSA-N
SynonymCS-0035657 | hexaethyleneglycol monobenzyl ether | HY-W042654 | DTXSID00457434 | Hexaethylene Glycol Monobenzyl Ether | 2-[2-[2-[2-[2-(2-phenylmethoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol | J-507639 | ZB0925 | 2,5,8,11,14,17-Hexaoxanonadecan-19-ol, 1
CAS No.24342-68-5
PubChem CID11164646

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTKQI986 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTIYX836 route compound structure diagram
    ACTIYX8362615-15-8 In Stock
  4. Then
  5. ACTKQI986 route product structure diagram
    ACTKQI98624342-68-5 In Stock
Inquiry

2. ACTKQI986 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTIYX836 route compound structure diagram
    ACTIYX8362615-15-8 In Stock
  4. Then
  5. ACTKQI986 route product structure diagram
    ACTKQI98624342-68-5 In Stock
Inquiry

Comments (0)